Affect Therapeutics
New York, US · Founded 2020 · Delaware corporation · 5 known investors
Affect provides integrated mental health and addiction treatment through a smartphone app, combining therapy, medication management, and behavioral incentives. The program serves individuals seeking confidential care for mental health and substance use disorders.
Founders & leadership
KR
Kevin RyanDirector
KM
Kristin MuhlnerExecutive Officer, Director
JR
Jeff RinehartDirector
JD
Jeff DeFlavioDirector
Investors · 5
Reported raises · per SEC filings
Form D private placements▶$18.1MraisedJul 2023 · 9 investors · Other Health CareRule 506(b)
▶$18.1MraisedJul 2023 · 9 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jeff RinehartDirector
- Kevin RyanDirector
- Jeff DeFlavioDirector
- Stuart PetersonDirector
- Kristin MuhlnerExecutive Officer, Director
- Offering amount
- $18.1M
- Amount sold
- $18.1M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$6.5MraisedSep 2021 · 10 investors · OtherRule 506(b)
▶$6.5MraisedSep 2021 · 10 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Kevin RyanDirector
- Kristin MuhlnerExecutive Officer, Director
- Jeff RinehartDirector
- Jeff DeFlavioDirector
- Offering amount
- $6.5M
- Amount sold
- $6.5M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.